Metformin promotes survivin degradation through AMPK/PKA/GSK-3β-axis in non-small cell lung cancer

Journal of Cellular Biochemistry
Zhuang LuoShaoqing Shi

Abstract

Metformin, a first-line antidiabetic drug, has been reported with anticancer activities in many types of cancer. However, its molecular mechanisms remain largely unknown. As a member of inhibitor of apoptosis proteins, survivin plays an important role in the regulation of cell death. In the present study, we investigated the role of survivin in metformin-induced anticancer activity in non-small cell lung cancer in vitro. Metformin mainly induced apoptotic cell death in A549 and H460 cell lines. It remarkably suppressed the expression of survivin, decreased the stability of this protein, then promoted its proteasomal degradation. Moreover, metformin greatly suppressed protein kinase A (PKA) activity and induced its downstream glycogen synthase kinase 3β (GSK-3β) activation. PKA activators, both 8-Br-cAMP and forskolin, significantly increased the expression of survivin. Consistently both GSK-3β inhibitor LiCl and siRNA restored the expression of survivin in lung cancer cells. Furthermore, metformin induced adenosine 5'-monophosphate-activated protein kinase (AMPK) activation. Suppression of the activity of AMPK with Compound C reversed the degradation of survivin induced by metformin, and meanwhile, restored the activity of PKA ...Continue Reading

References

Aug 1, 1997·Nature Medicine·G AmbrosiniD C Altieri
Oct 18, 2000·Proceedings of the National Academy of Sciences of the United States of America·X FangG B Mills
Nov 30, 2000·Molecular and Cellular Biology·M LiK A Heidenreich
Apr 26, 2005·BMJ : British Medical Journal·Josie M M EvansAndrew D Morris
Mar 8, 2007·Carcinogenesis·Marzia PennatiNadia Zaffaroni
Dec 14, 2007·Nature Reviews. Cancer·Dario C Altieri
May 27, 2010·International Journal of Cancer. Journal International Du Cancer·Qin WangDaniel Y Wu
May 3, 2011·Neoplasia : an International Journal for Oncology Research·Ramandeep RattanViji Shridhar
Feb 2, 2012·Nature Reviews. Drug Discovery·Simone Fulda, Domagoj Vucic
May 23, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Floriana MorgilloFortunato Ciardiello
Aug 15, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Longyi ZhengHongyang Wang
Jan 8, 2014·Nature Reviews. Endocrinology·Ida Pernicova, Márta Korbonits
Mar 26, 2014·Oncogene·A G BeristainR Khokha
Jul 30, 2014·Methods in Enzymology·John Silke, Domagoj Vucic
Aug 2, 2014·International Journal of Cancer. Journal International Du Cancer·Floris H GroenendijkRené Bernards
Oct 1, 2014·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Ming-Ju TsaiHerng-Chia Chiu
Apr 30, 2016·Molecular Carcinogenesis·HyeRan GwakYong Sang Song
Mar 23, 2017·Breast Cancer Research and Treatment·Elena StrekalovaVincent L Cryns
Apr 6, 2017·International Journal of Cancer. Journal International Du Cancer·Jie LinKangmin Zhu
Feb 9, 2018·Cell Death & Disease·Xiaojie YuAlexander Pertsemlidis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.